FDA finalizes cosmetics recall guidance, with no substantive change from draft
The October 22 guidance explains how FDA may use its mandatory cosmetics-recall authority under MoCRA. It clarifies the process but does not create a new recall power.
Final guidance
What changed?
On October 22, the Food and Drug Administration finalized its guidance on mandatory cosmetics recalls under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). FDA said the final version made no substantive changes to the December 2025 draft.
The document explains when FDA may order a recall, the steps the agency will follow, and what it expects from businesses subject to a mandatory recall order. FDA continues to encourage voluntary recalls of products that violate the law.
Why does it matter?
The legal authority already existed under MoCRA. What changed this month is the status of the guidance: companies now have a final FDA explanation of the recall process, rather than a draft to review.
Cosmetics brands and manufacturers should use it to check whether their recall procedures, distribution records and escalation contacts would let them respond promptly. Final guidance is not itself evidence of an increased number of recalls or new statutory obligations.
Who is most exposed?
Cosmetics manufacturers, private-label brands, importers and distributors that control product records and recall communications. Retailers may need to coordinate removal of affected products if a recall occurs.
What should businesses watch next?
FDA recall notices and warning letters; any future amendments to MoCRA implementation; and whether suppliers can quickly identify affected batches and distribution channels.
U.S. Food and Drug Administration — final cosmetics recall guidance, October 22
Trend check: A regulatory implementation milestone, not a newly enacted requirement or evidence of a rise in recalls.
Related Industry Intelligence: Beauty & Personal Care